For decades, clinicians and researchers have recognized that some people with type 2 diabetes of short duration who adhere to intensive glucose-lowering therapy can achieve normal blood glucose levels and discontinue treatment.
This remission of diabetes can last for years and is associated with improved insulin secretion and even insulin resistance. More recently, researchers involved with the STAMPEDE trial showed that diabetes remission can be achieved by patients with longer duration type 2 diabetes who undergo bariatric surgery.
In a consensus report published last year in Diabetes Care